Publication: Evaluation of 3-O-methyldopa as a biomarker for aromatic L-amino acid decarboxylase deficiency in 7 Brazilian cases
This research article, published in Molecular Genetics and Metabolism Reports, evaluates and validates 3-O-methyldopa (3-OMD) as a biomarker for aromatic L-amino acid decarboxylase (AADC) deficiency
Learn about the validation of 3-OMD as a reliable and stable marker for the identification of AADC deficiency, using dried blood spot (DBS) samples of 7 AADC deficiency patients and 35 non-AADC deficiency controls
Understand the limitations of current diagnostic tests for AADC deficiency
Recognize the potential utility of 3-OMD quantification performed in DBS’ in newborn screening
Kubaski F, et al. Mol Genet Metab Rep. 2021;27:100744
Once registered, you will be able to view the abstract and be provided the DOI and PubMed links for this publication.
Register now to unlock the content
Register now to access the content on this page
If not, register below
MED-ALL-AADC-2200023 | March 2022
Sign in or register to access exclusive content on this site
Some cookies are essential, others help us improve your experience by providing insights into how the website is used. Select one or more of the cookie types listed below, and then save your preferences. Refer to our Cookies Statement for more information.
Performance cookies, which help us measure the website’s performance and improve your experience. In using performance cookies we do not store any personal data, and only use the information collected through these cookies in aggregated and anonymised form.